39 min ago
Dendreon: Where Things Stand Now
It's been a couple of weeks now since biotech name Dendreon reported another awful quarter .
Thu Dec 05, 2013
RBCC Appoints New CEO to Achieve Regenerative Medicine Goals
A registered nurse with extensive healthcare experience, Palmer will be tasked with implementing RBCC's developing business strategy in the field of regenerative medicine.
Wed Dec 04, 2013
Juno Therapeutics cancer therapy startup raises $120M
Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center , and Seattle Children's Research Institute - said it's raised $120 million in Series A funding to create treatments for CEO of the new company will be Hans Bishop , who formerly was the COO of Seattle-based Dendreon Corp. .
Tue Dec 03, 2013
Analyst who cast doubt on Provenge vaccine settles with SEC
A former hedge-fund analyst who argued that Dendreon Corp's therapeutic vaccine for prostate cancer may hasten the death of patients has reached a settlement with U.S. securities regulators over failure to disclose her financial interests in the company.
Stock's Buzzers - Dendreon Corporation (NASDAQ:DNDN), Ruckus Wireless ...
Value Penny Stocks issues special report on Dendreon Corporation , Ruckus Wireless Inc , Universal Insurance Holdings, Inc. , Endeavour Silver Corp .
Mon Dec 02, 2013
If Northwest Biotherapeutics Wins, It Wins Big
There have been some debates about Northwest Biotherapeutics in the past few quarters.
Tue Nov 26, 2013
Dendreon Announces Webcast Presentation at Deutsche Bank BioFEST Conference
Dendreon Corporation today announced that management will present at the 6th Annual Deutsche Bank BioFEST Conference in Boston, Massachusetts on December 3, 2013 at 3:25 p.m. ET.
Merrimack Pharmaceuticals: Speculation Is An Investor's Best Friend
One of the most exciting aspects of biotechs is their ability to skyrocket on rumors or plain old rampant speculation.
Sat Nov 23, 2013
Active Movers - Vonage Holdings Corp.(NYSE:VG), Dendreon Corporation...
CaddyStocks.com is keen to discover penny stocks with the potential to make short and long-term gains.
Fri Nov 22, 2013
Celldex: Tune In For Monday's Conference Call On Rindopepimut
Celldex has raised expectations for positive results for rindopepimut in recurrent glioblastoma.
Wed Nov 20, 2013
Stock's Trend Analysis Report - Alkaline Water Company Inc...
High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout.
Special News Alert: Organovo Holdings Inc
Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages.
Tue Nov 19, 2013
Tuesday's ETF Movers: XBI, ILF
In trading on Tuesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.1% on the day.
Mon Nov 18, 2013
Midday Market Stats: Dow Jones Industrial Average Moves Higher Despite Flat Home Builder Index
The Dow Jones Industrial Average is up 50.1 points, or 0.3%, at 16,011.77 -- just off a record high of 16,030.28 touched a few minutes into the session -- as the index continues to test the psychologically significant 16,000 level.
Investor's Alert: Sony Corporation (ADR) (NYSE:SNE), Dendreon...
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and "in-play" momentum penny stocks.
Fri Nov 15, 2013
Thu Nov 14, 2013
Histogenics Announces Appointment of John H. Johnson to Its Board of Directors
Histogenics Corporation, a late stage company focused on regenerative medicine technologies, today announced that John H. Johnson has been appointed to the company's board of directors.
Wed Nov 13, 2013
Dendreon: A Classic Plan Of Desperation
Dendreon reported a mixed earnings report yesterday, and immediately saw gains of more than 4%.
Dendreon Has Another Disaster Quarter
In recent years, when it comes to short ideas, biotech firm Dendreon has been my greatest pick.
Analyst Downgrades: Dendreon Corporation (DNDN), Wynn Resorts,...
Specifically, Needham downgraded the equity to "hold" from "buy," while both William Blair and Jefferies dropped their respective price targets to $2 from $3.